SEC Comment Letter for Rezolute, Inc. (RZLT) (CIK 0001509261) (RZLT) — Apr 8, 2014
Rezolute, Inc. (RZLT) (CIK 0001509261)
Date: April 8, 2014 · CIK: 0001509261 · Accession: 0000000000-14-017556
AI Filing Summary & Sentiment
File numbers found in text: 000-54495
Show Raw Text
April 8, 2014 Via E -mail Nevan Elam Chief Executive Officer AntriaBio, Inc. 890 Santa Cruz Avenue Menlo Park , CA 94025 Re: AntriaBio, Inc. Preliminary Proxy Statement on Schedule 14C Filed March 31 , 2014 File No. 000-54495 Dear Mr. Elam : We have completed our review of your filing . We remind you that our comments or changes to disclosure in response to our comments do not foreclose the Commission from taking any action with respect to the company or the filing and the company may not assert staff comments as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States. We urge all persons who are responsible for the accuracy and adequacy of the disclosure in the filing to be certain that the filing includes the information the Securities Exchange Act of 1934 and all applicable rules require. Sincerely, /s/ Daniel Greenspan for Jeffrey P. Riedler Assistant Director cc: Via E -mail Anthony W. Epps Dorsey & Whitney LLP 1400 Wewatta Street Suite 400 Denver, CO 80202 -5549